
Asia Pacific Lancet Pen Needels Market Trends
Lancet and Pen Needles Market Research Report, By Therapy (Insulin, (GLP-1), Growth Hormones), Gauge (17/18G, 21G, 23G), Needle Length (4mm, 8mm, 12mm), And End Users (Medical Institutions & Research Organizations) – The Asia Pacific Forecast till 2035

Market Summary
The Asia-Pacific Lancet and Pen Needles market is projected to grow significantly from 1.95 USD Billion in 2024 to 4.93 USD Billion by 2035.
Key Market Trends & Highlights
Asia Pacific Lancet and Pen Needles Key Trends and Highlights
- The market is expected to expand at a compound annual growth rate (CAGR) of 8.81% from 2025 to 2035.
- By 2035, the market value is anticipated to reach 4.93 USD Billion, indicating robust growth potential.
- In 2024, the market is valued at 1.95 USD Billion, laying a strong foundation for future expansion.
- Growing adoption of advanced pen needle technology due to increasing prevalence of diabetes is a major market driver.
Market Size & Forecast
2024 Market Size | 1.95 (USD Billion) |
2035 Market Size | 4.93 (USD Billion) |
CAGR (2025-2035) | 8.81% |
Largest Regional Market Share in 2024 | latin_america) |
Major Players
BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe)
Market Trends
Asia Pacific Lancet Pen Needels Market Market Drivers
Market Segment Insights
Regional Insights
Key Companies in the Asia Pacific Lancet Pen Needels Market market include


Industry Developments
February 2024: Eli Lilly hopes to launch its bestselling antidiabetic medication, specified as Mounjaro (tripeptide), which will be around early next year. Indian health regulatory bodies, including Mounjaro, are currently investigating this.
According to Minister Mykhailo Fedorov for Digital Transformation in Ukraine, contracts will be signed first about the mass production of attack drones similar to Russian Lancet drones in February 2024. Among them is the kamikaze drone Lancet manufactured by ZALA Aero Group, which has a range of forty kilometers and belongs to Kalashnikov Concern’s large enterprise division, Russian Armaments Manufacturer.June 2023: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited (SML), was granted marketing authorization for its Adalimumab injection in prefilled syringe (PFS). It is a biosimilar for high concentration adalimumab formulation for rheumatoid arthritis treatment.
During CPHI Japan 2023, SHL Medical introduced Molly modular platform autoinjectors with pre-installed Needle Isolation Technology (NIT).
September 2022: The Microsoft and Novo Nordisk partnership was announced in September 2022, merging computational services, cloud computing AI and knowledge thirst in drug development as well as Novo Nordisk’s data engineering services.
On September 2022, Novo Nordisk acquired Forma Therapeutics. That company is committed to changing lives of Sickle cell disease (SCD) patients among other rare blood diseases.
Market Segmentation
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Asia Pacific Lancet and Pen Needles Market Overview
- Pharmaceutical companies
- Biotechnological institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Key Players for Asia Pacific Lancet and Pen Needles Market
- BD. (U.S.)
- Novo Nordisk A/S (Europe)
- Ypsomed (Europe)
- B. Braun Melsungen AG (Europe)
- HTL-STREFA (Europe)
- Terumo Corporation (Asia Pacific)
- Artsana S.p.A. (Europe)
- Owen Mumford Ltd. (Europe)
Report Scope
Attribute/Metric | Details |
Market Size 2030 | USD 3.45 Billion 2032 |
Compound Annual Growth Rate (CAGR) | 12.67% 2032 |
Base Year | 2021 |
Market Forecast Period | 2024-2032 |
Historical Data | 2018 - 2021 |
Market Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, technology, application, and end-users. |
Geographies Covered | Americas, Europe, Asia Pacific and the Middle East and Africa |
Countries Covered | China, Japan, India, Australia, South Korea, Australia, Rest of Asia-Pacific |
Key Companies Profiled | BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe). |
Key Market Opportunities | Key market opportunities in the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing healthcare expenditure, and growing awareness about advanced diabetes management technologies. |
Key Market Dynamics | The key market dynamics for the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing adoption of self-monitoring blood glucose devices, technological advancements in needle design, growing awareness and patient education, and expanding healthcare infrastructure. |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
-
TABLE OF CONTENT
-
Chapter 1. Report Prologue
-
Chapter 2. Market Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Chapter 3. Research Methodology
- Introduction
- Primary Research
- Secondary research
- Market Size Estimation
-
Chapter 4. Market Dynamics
- Drivers
- Restrains
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends & Assessment
-
Chapter 5. Market Factor Analysis
-
Porters Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
-
Porters Five Forces Analysis
-
Chapter 6. Asia Pacific Lancet and Pen Needles, by Therapy
- Introduction
- Insulin
-
Market Estimates & Forecast, 2017 – 2023
- Glucagon-Like Peptide-1 (GLP-1)
-
Market Estimates & Forecast, 2017 – 2023
- Growth Hormones
- Others
-
Chapter 7. Asia Pacific Lancet and Pen Needles, by Gauge
- Introduction
- 17/18G
- 21G
- 23G
-
Market Estimates & Forecast, 2017 – 2023
- Others
-
Chapter 8. Asia Pacific Lancet and Pen Needles, by Needle Length
- Introduction
- 4mm
- 8mm
- 12mm
- Others
-
Chapter 9 Asia Pacific Lancet and Pen Needles, by End User
- Introduction
- Hospitals & Clinics
-
Medical Institutions & Research Organizations
- Market Estimates & Forecast, 2017 – 2023
- Others
-
Chapter 10. Asia Pacific Lancet and Pen Needles, by Region
-
Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
-
Asia Pacific
-
Chapter 11 Company Landscape
- Introduction
- Market Share Analysis
-
Key Development & Strategies
- Key Developments
-
Chapter 12 Company Profiles
-
BD.
- Company Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Novo Nordisk A/S
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Ypsomed
- Company Overview
- Product Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
B. Braun Melsungen AG
- Company Overview
- Product/Business Segment Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
HTL-STREFA
- Company Overview
- Product Overview
- Financial overview
- Key Developments
- SWOT Analysis
-
Terumo Corporation
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Artsana S.p.A.
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
-
Owen Mumford Ltd.
- Overview
- Product Overview
- Financials
- Key Developments
- SWOT Analysis
- Others
-
BD.
-
Chapter 13 MRFR Conclusion
-
Key Findings
- From CEO’s View Point
- Unmet Needs of the Market
- Key Companies to Watch
- Prediction of Lancet and Pen Needles industry
-
Key Findings
-
Chapter 14 Appendix
-
List of Tables and Figures
- LIST OF TABLES
- Table 1 Lancet and Pen Needles Industry Synopsis, 2020-2027
- Table 2 Asia Pacific Lancet and Pen Needles Market Estimates and Forecast, 2020-2027, (USD Million)
- Table 3 Asia Pacific Lancet and Pen Needles Market by Region, 2020-2027, (USD Million)
- Table 4 Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 5 Asia Pacific Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 6 Asia Pacific Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
- Table 7 Asia Pacific Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
- Table 8 Japan Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 9 Japan Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 10 Japan Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
- Table 11 Japan Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
- Table 12 China Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 13 China Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 14 China Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
- Table 15 China Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
- Table 16 India Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 17 India Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 18 India Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
- Table 19 India Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
- Table 20 Republic of Korea Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 21 Republic of Korea Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 22 Republic of Korea Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
- Table 23 Republic of Korea Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
- Table 24 Rest of Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
- Table 25 Rest of Asia Pacific Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
- Table 26 Rest of Asia Pacific Lancet and Pen Needles Market by Needle Lenght, 2020-2027, (USD Million)
- Table 27 Rest of Asia Pacific Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million) LIST OF FIGURES
- Figure 1 Research Process
- Figure 2 Segmentation for Asia Pacific Lancet and Pen Needles Market
- Figure 3 Market Dynamics for Asia Pacific Lancet and Pen Needles Market
- Figure 4 Asia Pacific Lancet and Pen Needles Market Share, by Therapy 2020
- Figure 5 Asia Pacific Lancet and Pen Needles Market Share, by Gauge 2020
- Figure 6 Asia Pacific Lancet and Pen Needles Market Share, by Needle Lenght 2020
- Figure 7 Asia Pacific Lancet and Pen Needles Market Share, by End Users, 2020
- Figure 8 Asia Pacific Lancet and Pen Needles Market Share, by Region, 2020
- Figure 9 Asia Pacific Lancet and Pen Needles Market Share, by Country, 2020
- Figure 10 Asia Pacific Lancet and Pen Needles: Company Share Analysis, 2020 (%)
- Figure 11 BD.: Key Financials
- Figure 12 BD.: Segmental Revenue
- Figure 13 BD.: Geographical Revenue
- Figure 14 Novo Nordisk A/S: Key Financials
- Figure 15 Novo Nordisk A/S: Segmental Revenue
- Figure 16 Novo Nordisk A/S: Geographical Revenue
- Figure 17 Ypsomed: Key Financials
- Figure 18 Ypsomed: Segmental Revenue
- Figure 19 Ypsomed: Geographical Revenue
- Figure 20 B. Braun Melsungen AG: Key Financials
- Figure 21 B. Braun Melsungen AG: Segmental Revenue
- Figure 22 B. Braun Melsungen AG: Geographical Revenue
- Figure 23 HTL-STREFA: Key Financials
- Figure 24 HTL-STREFA: Segmental Revenue
- Figure 25 HTL-STREFA: Geographical Revenue
- Figure 26 Terumo Corporation: Key Financials
- Figure 27 Terumo Corporation: Segmental Revenue
- Figure 28 Terumo Corporation: Geographical Revenue
- Figure 29 Artsana S.p.A.: Key Financials
- Figure 30 Artsana S.p.A.: Segmental Revenue
- Figure 31 Artsana S.p.A.: Geographical Revenue
- Figure 32 Owen Mumford Ltd.: Key Financials
- Figure 33 Owen Mumford Ltd.: Segmental Revenue
- Figure 34 Owen Mumford Ltd.: Geographical Revenue
Lancet and Pen Needles Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment